Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- Check6 days agoChange DetectedThe study page now returns a 403 Forbidden error, removing the detailed study content and documents from view. A minimal 403 page with site navigation is displayed instead.SummaryDifference16%

- Check13 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the page metadata. This change does not modify the study content or how users interact with the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedA new page revision entry was added: Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page or site metadata without altering study content or user-facing features.SummaryDifference0.1%

- Check35 days agoChange DetectedA new entry, '2017 ( U.S. NIH Grant/Contract )', was added to the study's identifiers/funding section, recording NIH funding for the trial.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now displays a new revision label (v3.6.5) replacing the previous v3.6.4, indicating an update to the page's backend or content management system.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision tag on the page has been updated from v3.6.3 to v3.6.4. This indicates a minor version update rather than a substantive content change.SummaryDifference0.1%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.